odafosfamide

Odafosfamide is an experimental oxazaphosphorine alkylating agent that appears to be a structural and functional analogue or derivative of ifosfamide, designed to generate cytotoxic phosphoramide mustard species that cross-link DNA and thereby inhibit DNA replication and transcription in rapidly dividing tumor cells. Like other nitrogen mustard–derived oxazaphosphorines, it is expected to act as a prodrug requiring metabolic or chemical activation to produce bifunctional alkylating metabolites that induce interstrand and intrastrand DNA cross-links at guanine N-7 positions, leading to cell-cycle arrest and apoptosis in malignant cells. Publicly available information on odafosfamide is extremely limited, and its specific developer, optimized activation pathway, pharmacokinetic properties, and clinical development program have not been clearly characterized in accessible literature.